337
References
1. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek N, Soto A, et al. Endocrine-disrupting
chemicals and public health protection: a statement of principles from The Endocrine Society.
Endocrinology. 2012;153(9):4097–110.
2. Golub MS, Doherty JD. Triphenyltin as a potential human endocrine disruptor. J Toxicol
Environ Health B. 2004;7(4):281–95.
3. Mazur CS, Marchitti SA, Zastre J. P-glycoprotein inhibition by the agricultural pesticide
propiconazole and its hydroxylated metabolites: implications for pesticide–drug interactions.
Toxicol Lett. 2015;232(1):37–45.
4. Mumtaz M, George J, Gold K, Cibulas W, Derosa C. ATSDR evaluation of health effects of
chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): understanding a complex problem.
Toxicol Ind Health. 1996;12(6):742–971.
5. Marston CP, Pereira C, Ferguson J, Fischer K, Hedstrom O, Dashwood W-M, et al. Effect of
a complex environmental mixture from coal tar containing polycyclic aromatic hydrocarbons
(PAH) on the tumor initiation, PAH–DNA binding and metabolic activation of carcinogenic
PAH in mouse epidermis. Carcinogenesis. 2001;22(7):1077–86.
6. Baek S, Field R, Goldstone M, Kirk P, Lester J, Perry R. A review of atmospheric polycyclic aromatic hydrocarbons: sources, fate and behavior. Water Air Soil Pollut. 1991;60(3–4):279–300.
7. Buehler SS, Hites RA. Peer reviewed: the great lakes’ integrated atmospheric deposition network. Washington: ACS Publications; 2002.
8. Ramesh A, Walker SA, Hood DB, Guillén MD, Schneider K, Weyand EH. Bioavailability
and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol.
2004;23(5):301–33.
9. Keith L, Telliard W. ES&T special report: priority pollutants: I—a perspective view. Environ
Sci Technol. 1979;13(4):416–23.
10. Denissenko MF, Pao A, Tang M-s, Pfeifer GP. Preferential formation of benzo [a] pyrene
adducts at lung cancer mutational hotspots in P53. Science. 1996;274(5286):430–2.
11. Boström C-E, Gerde P, Hanberg A, Jernström B, Johansson C, Kyrklund T, et al. Cancer risk
assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air.
Environ Health Perspect. 2002;110(suppl 3):451–88.
12. Zhang Y, Ding J, Shen G, Zhong J, Wang C, Wei S, et al. Dietary and inhalation exposure to
polycyclic aromatic hydrocarbons and urinary excretion of monohydroxy metabolites–a controlled case study in Beijing, China. Environ Pollut. 2014;184:515–22.
13. Rubin H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis.
2001;22(12):1903–30.
14. Shen H, Huang Y, Wang R, Zhu D, Li W, Shen G, et al. Global atmospheric emissions of polycyclic aromatic hydrocarbons from 1960 to 2008 and future predictions. Environ Sci Technol.
2013;47(12):6415–24.
15. Li W, Wang C, Wang H, Chen J, Shen H, Shen G, et al. Atmospheric polycyclic aromatic
hydrocarbons in rural and urban areas of northern China. Environ Pollut. 2014;192:83–90.
16. McVeety BD, Hites RA. Atmospheric deposition of polycyclic aromatic hydrocarbons to
water surfaces: a mass balance approach. Atmos Environ. 1988;22(3):511–36.
17. Nam JJ, Sweetman AJ, Jones KC. Polynuclear aromatic hydrocarbons (PAHs) in global background soils. J Environ Monit. 2009;11(1):45–8.
18. Nam JJ, Thomas GO, Jaward FM, Steinnes E, Gustafsson O, Jones KC. PAHs in background
soils from Western Europe: influence of atmospheric deposition and soil organic matter.
Chemosphere. 2008;70(9):1596–602.
19. Cerniglia CE. Biodegradation of polycyclic aromatic hydrocarbons. Curr Opin Biotechnol.
1993;4(3):331–8.
19 Role of Polycyclic Aromatic Hydrocarbons as EDCs in Metabolic Disorders
References
1. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek N, Soto A, et al. Endocrine-disrupting
chemicals and public health protection: a statement of principles from The Endocrine Society.
Endocrinology. 2012;153(9):4097–110.
2. Golub MS, Doherty JD. Triphenyltin as a potential human endocrine disruptor. J Toxicol
Environ Health B. 2004;7(4):281–95.
3. Mazur CS, Marchitti SA, Zastre J. P-glycoprotein inhibition by the agricultural pesticide
propiconazole and its hydroxylated metabolites: implications for pesticide–drug interactions.
Toxicol Lett. 2015;232(1):37–45.
4. Mumtaz M, George J, Gold K, Cibulas W, Derosa C. ATSDR evaluation of health effects of
chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): understanding a complex problem.
Toxicol Ind Health. 1996;12(6):742–971.
5. Marston CP, Pereira C, Ferguson J, Fischer K, Hedstrom O, Dashwood W-M, et al. Effect of
a complex environmental mixture from coal tar containing polycyclic aromatic hydrocarbons
(PAH) on the tumor initiation, PAH–DNA binding and metabolic activation of carcinogenic
PAH in mouse epidermis. Carcinogenesis. 2001;22(7):1077–86.
6. Baek S, Field R, Goldstone M, Kirk P, Lester J, Perry R. A review of atmospheric polycyclic aromatic hydrocarbons: sources, fate and behavior. Water Air Soil Pollut. 1991;60(3–4):279–300.
7. Buehler SS, Hites RA. Peer reviewed: the great lakes’ integrated atmospheric deposition network. Washington: ACS Publications; 2002.
8. Ramesh A, Walker SA, Hood DB, Guillén MD, Schneider K, Weyand EH. Bioavailability
and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol.
2004;23(5):301–33.
9. Keith L, Telliard W. ES&T special report: priority pollutants: I—a perspective view. Environ
Sci Technol. 1979;13(4):416–23.
10. Denissenko MF, Pao A, Tang M-s, Pfeifer GP. Preferential formation of benzo [a] pyrene
adducts at lung cancer mutational hotspots in P53. Science. 1996;274(5286):430–2.
11. Boström C-E, Gerde P, Hanberg A, Jernström B, Johansson C, Kyrklund T, et al. Cancer risk
assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air.
Environ Health Perspect. 2002;110(suppl 3):451–88.
12. Zhang Y, Ding J, Shen G, Zhong J, Wang C, Wei S, et al. Dietary and inhalation exposure to
polycyclic aromatic hydrocarbons and urinary excretion of monohydroxy metabolites–a controlled case study in Beijing, China. Environ Pollut. 2014;184:515–22.
13. Rubin H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis.
2001;22(12):1903–30.
14. Shen H, Huang Y, Wang R, Zhu D, Li W, Shen G, et al. Global atmospheric emissions of polycyclic aromatic hydrocarbons from 1960 to 2008 and future predictions. Environ Sci Technol.
2013;47(12):6415–24.
15. Li W, Wang C, Wang H, Chen J, Shen H, Shen G, et al. Atmospheric polycyclic aromatic
hydrocarbons in rural and urban areas of northern China. Environ Pollut. 2014;192:83–90.
16. McVeety BD, Hites RA. Atmospheric deposition of polycyclic aromatic hydrocarbons to
water surfaces: a mass balance approach. Atmos Environ. 1988;22(3):511–36.
17. Nam JJ, Sweetman AJ, Jones KC. Polynuclear aromatic hydrocarbons (PAHs) in global background soils. J Environ Monit. 2009;11(1):45–8.
18. Nam JJ, Thomas GO, Jaward FM, Steinnes E, Gustafsson O, Jones KC. PAHs in background
soils from Western Europe: influence of atmospheric deposition and soil organic matter.
Chemosphere. 2008;70(9):1596–602.
19. Cerniglia CE. Biodegradation of polycyclic aromatic hydrocarbons. Curr Opin Biotechnol.
1993;4(3):331–8.
19 Role of Polycyclic Aromatic Hydrocarbons as EDCs in Metabolic Disorders